Literature DB >> 35470402

Evaluating the Effectiveness of Intranasal Butorphanol in Reducing Chronic Itch.

Angelina Labib, Teresa Ju, Zoe Morgan Lipman, Gil Yosipovitch1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35470402      PMCID： PMC9574675          DOI： 10.2340/actadv.v102.2153

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  14 in total

1.  Itch severity and quality of life in patients with pruritus: preliminary validity of a Danish adaptation of the itch severity scale.

Authors:  Robert Zachariae; Ulrikke Lei; Merete Haedersdal; Claus Zachariae
Journal:  Acta Derm Venereol       Date:  2012-09       Impact factor: 4.437

2.  Intranasal butorphanol rescue therapy for the treatment of intractable pruritus: A case series from the Johns Hopkins Itch Clinic.

Authors:  Raveena Khanna; Christina D Kwon; Sagar P Patel; Micah Belzberg; Kyle A Williams; Ramona Khanna; Emily Boozalis; Shawn G Kwatra
Journal:  J Am Acad Dermatol       Date:  2020-07-15       Impact factor: 11.527

3.  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus.

Authors:  Vandana S Mathur; Jayant Kumar; Paul W Crawford; Howard Hait; Thomas Sciascia
Journal:  Am J Nephrol       Date:  2017-12-18       Impact factor: 3.754

4.  Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase.

Authors:  E Weisshaar; J C Szepietowski; J D Bernhard; H Hait; F J Legat; L Nattkemper; A Reich; B Sadoghi; T R Sciascia; C Zeidler; G Yosipovitch; S Ständer
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-12-01       Impact factor: 6.166

Review 5.  Difelikefalin: First Approval.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2021-11       Impact factor: 9.546

6.  Butorphanol for treatment of intractable pruritus.

Authors:  Aerlyn G Dawn; Gil Yosipovitch
Journal:  J Am Acad Dermatol       Date:  2006-01-18       Impact factor: 11.527

7.  Efficacy and safety of a novel ĸ-agonist for managing intractable pruritus in dialysis patients.

Authors:  Hiroo Kumagai; Toshiya Ebata; Kenji Takamori; Katsumasa Miyasato; Taro Muramatsu; Hidetomo Nakamoto; Masanao Kurihara; Tomoji Yanagita; Hiromichi Suzuki
Journal:  Am J Nephrol       Date:  2012-08-03       Impact factor: 3.754

Review 8.  Therapeutic Potential of Kappa Opioid Agonists.

Authors:  Tyler C Beck; Matthew A Hapstack; Kyle R Beck; Thomas A Dix
Journal:  Pharmaceuticals (Basel)       Date:  2019-06-20

9.  Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.

Authors:  G Yosipovitch; M Reaney; V Mastey; L Eckert; A Abbé; L Nelson; M Clark; N Williams; Z Chen; M Ardeleanu; B Akinlade; N M H Graham; G Pirozzi; H Staudinger; S Plaum; A Radin; A Gadkari
Journal:  Br J Dermatol       Date:  2019-05-01       Impact factor: 9.302

Review 10.  Intractable Itch in Atopic Dermatitis: Causes and Treatments.

Authors:  Yoshie Umehara; Chanisa Kiatsurayanon; Juan Valentin Trujillo-Paez; Panjit Chieosilapatham; Ge Peng; Hainan Yue; Hai Le Thanh Nguyen; Pu Song; Ko Okumura; Hideoki Ogawa; François Niyonsaba
Journal:  Biomedicines       Date:  2021-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.